Tumour treating fields therapy for glioblastoma: current advances and future directions
Open Access
- 3 November 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 124 (4), 697-709
- https://doi.org/10.1038/s41416-020-01136-5
Abstract
Glioblastoma multiforme (GBM) is the most common primary brain tumour in adults and continues to portend poor survival, despite multimodal treatment using surgery and chemoradiotherapy. The addition of tumour-treating fields (TTFields)-an approach in which alternating electrical fields exert biophysical force on charged and polarisable molecules known as dipoles-to standard therapy, has been shown to extend survival for patients with newly diagnosed GBM, recurrent GBM and mesothelioma, leading to the clinical approval of this approach by the FDA. TTFields represent a non-invasive anticancer modality consisting of low-intensity (1-3 V/cm), intermediate-frequency (100-300 kHz), alternating electric fields delivered via cutaneous transducer arrays configured to provide optimal tumour-site coverage. Although TTFields were initially demonstrated to inhibit cancer cell proliferation by interfering with mitotic apparatus, it is becoming increasingly clear that TTFields show a broad mechanism of action by disrupting a multitude of biological processes, including DNA repair, cell permeability and immunological responses, to elicit therapeutic effects. This review describes advances in our current understanding of the mechanisms by which TTFields mediate anticancer effects. Additionally, we summarise the landscape of TTFields clinical trials across various cancers and consider how emerging preclinical data might inform future clinical applications for TTFields.This publication has 119 references indexed in Scilit:
- A phase I/II trial of Tumor Treating Fields (TTFields) therapy in combination with pemetrexed for advanced non-small cell lung cancerLung Cancer, 2013
- Tumor treating fields: a new frontier in cancer therapyAnnals of the New York Academy of Sciences, 2013
- An Anillin-Ect2 Complex Stabilizes Central Spindle Microtubules at the Cortex during CytokinesisPLOS ONE, 2012
- Conditional Survival of All Primary Brain Tumor Patients by Age, Behavior, and HistologyNeuroepidemiology, 2011
- Stabilization of the Actomyosin Ring Enables Spermatocyte Cytokinesis in DrosophilaMolecular Biology of the Cell, 2010
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Alternating electric fields (TTFields) inhibit metastatic spread of solid tumors to the lungsClinical & Experimental Metastasis, 2009
- Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumorsProceedings of the National Academy of Sciences of the United States of America, 2007
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- The spindle checkpoint: structural insights into dynamic signallingNature Reviews Molecular Cell Biology, 2002